SOPHARMA AD - Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC)

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 9 / 2021

Date of issue: 2021-03-26

Short name of the issuer

SOPHARMA AD

Subject

Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC)

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Sopharma AD invites all shareholders of the Company to exercise their voting right on the announced agenda items of the Extraordinary General Meeting convened for 2 April 2021 from 11:00 a.m. (8:00 a.m.) through correspondence. In an effort to preserve the normal operation of all the bodies of “Sopharma” AD and at the same time not to jeopardize the health of the interested parties in the conditions of a pandemic, the Board of Directors provide an opportunity for shareholders to exercise their voting rights in advance. The rules for voting by correspondence are described in detail in the invitation to convene the General Meeting. A sample declaration for voting by correspondence is attached to it.

Annexes

File Description

SFA_2021_EGM_notification_espi.pdf Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC)

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2021-03-26 Ognian Donev Executive Director